Aeterna Zentaris Inc
TSX:AEZS

Watchlist Manager
Aeterna Zentaris Inc Logo
Aeterna Zentaris Inc
TSX:AEZS
Watchlist
Price: 5.1 CAD -0.97%
Market Cap: 18.9m CAD

Wall Street
Price Targets

AEZS Price Targets Summary
Aeterna Zentaris Inc

There are no price targets for AEZS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Aeterna Zentaris Inc Competitors:
Price Targets
6855
Ascentage Pharma Group International
86% Upside
688180
Shanghai Junshi Biosciences Co Ltd
28% Downside
300601
Shenzhen Kangtai Biological Products Co Ltd
32% Upside
ARQT
Arcutis Biotherapeutics Inc
12% Upside
RNA
Avidity Biosciences Inc
3% Upside
CPRX
Catalyst Pharmaceuticals Inc
46% Upside
ORY
Oryzon Genomics SA
145% Upside
GILD
Gilead Sciences Inc
11% Upside

Revenue
Forecast

Revenue Estimate
Aeterna Zentaris Inc

For the last 8 years the compound annual growth rate for Aeterna Zentaris Inc's revenue is 32%. The projected CAGR for the next 1 year is -2%.

32%
Past Growth
-2%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Aeterna Zentaris Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Aeterna Zentaris Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-76%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AEZS's stock price target?
Not Available

AEZS doesn't have any price targets made by Wall Street professionals.

What is Aeterna Zentaris Inc's Revenue forecast?
Projected CAGR
-2%

For the last 8 years the compound annual growth rate for Aeterna Zentaris Inc's revenue is 32%. The projected CAGR for the next 1 year is -2%.

Back to Top